
Mercury Laboratories Ltd Falls to 52-Week Low of Rs 620.55 as Sell-Off Deepens
2026-04-24 15:35:09A sharp decline of 19.41% intraday has dragged Mercury Laboratories Ltd to a fresh 52-week low of Rs 620.55 on 24 Apr 2026, marking a significant setback for the micro-cap pharmaceutical player amid a broadly weak market environment.
Read More
Mercury Laboratories Ltd is Rated Strong Sell
2026-04-21 10:10:52Mercury Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 21 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read More
Mercury Laboratories Ltd is Rated Strong Sell
2026-04-10 10:10:57Mercury Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 10 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Change in Management
11-Jun-2026 | Source : BSEIntimation about the appointment of Plant head is attached
Announcement under Regulation 30 (LODR)-Newspaper Publication
31-May-2026 | Source : BSENewspaper publication of audited financial statement for the quarter and year ended on 31.03.2026 is attached
Corrigendum To Audited Financial Results Of The Company For The Quarter And Financial Year Ended On March 31 2026
29-May-2026 | Source : BSECorrigendum to audited financial statement results for the quarter and year ended on 31.03.2026 is attached
Corporate Actions
No Upcoming Board Meetings
Mercury Laboratories Ltd has declared 35% dividend, ex-date: 06 Aug 25
No Splits history available
No Bonus history available
No Rights history available